title: Comparison of aripiprazole and other atypical antipsychotics for pediatric bipolar disorder: a retrospective chart review of efficacy and tolerability.
abstract: OBJECTIVE
  This study compared the efficacy and tolerability of aripiprazole with that of other atypical antipsychotics by examining patients with pediatric bipolar disorder (PBD) at a child and adolescent psychiatric clinic in a university hospital in Korea.
  
  
  METHODS
  We reviewed the medical records of 127 pediatric patients with bipolar disorder aged 4-18 years treated at Department of Child and Adolescent Psychiatric, Yonsei University Severance Hospital between January 2010 and October 2011 to collect demographic and clinical data. Using the Clinical Global Impression (CGI) scales, we evaluated levels of severity of and improvements in symptoms at the first, second, third, fourth, and fifth hospital visits.
  
  
  RESULTS
  The mean age of patients was 12.29±3.47 years. The sample included 91 (71.7%) male and 36 (28.3%) female patients. Aripiprazole was prescribed to 62 (48.8%) patients, risperidone to 52 (40.9%), quetiapine to 11 (8.7%), and paliperidone to two (1.6%). Patients treated with aripiprazole had lower CGI-Severity (CGI-S) scores than did patients treated with other atypical antipsychotics at the second and third visits. The CGI-Improvement (CGI-I) scores of patients treated with aripiprazole were lower at the second visit. Treatment with atypical antipsychotics was well tolerated, and no serious or fatal side effects were observed.
  
  
  CONCLUSIONS
  The present retrospective chart review suggests that atypical antipsychotics may be effective and safe for the treatment of patients with PBD. In particular, treatment with aripiprazole may be more effective than treatment with other atypical antipsychotics in the early phase. These results should be verified in future multi-center controlled studies.
authors.affiliation: Division of Child and Adolescent Psychiatry, Department of Psychiatry and Institute of Behavioral Science in Medicine, Yonsei University College of Medicine, Seoul, Korea.
authors.forename: Jooyoung
authors.initials: J
authors.lastname: Oh
authors.forename: Jhin Goo
authors.initials: JG
authors.lastname: Chang
authors.forename: Seul Bi
authors.initials: SB
authors.lastname: Lee
authors.forename: Dong-Ho
authors.initials: DH
authors.lastname: Song
authors.forename: Keun-Ah
authors.initials: KA
authors.lastname: Cheon
keywords: Antipsychotic agents; Aripiprazole; Bipolar disorder; Child psychiatry
references.citation: J Am Acad Child Adolesc Psychiatry. 2007 Jan;46(1):107-125
references.pmid: 17195735
references.citation: J Am Acad Child Adolesc Psychiatry. 2004 Jul;43(7):859-67
references.pmid: 15213587
references.citation: J Clin Psychiatry. 2006 Apr;67(4):509-16
references.pmid: 16669715
references.citation: Bipolar Disord. 2011 Aug-Sep;13(5-6):509-21
references.pmid: 22017220
references.citation: Schizophr Res. 2003 Jun 1;61(2-3):123-36
references.pmid: 12729864
references.citation: Can J Psychiatry. 1986 Feb;31(1):70-2
references.pmid: 3948110
references.citation: J Child Adolesc Psychopharmacol. 2009 Oct;19(5):553-61
references.pmid: 19877980
references.citation: J Clin Psychiatry. 2012 Jan;73(1):57-63
references.pmid: 22152402
references.citation: Biol Psychiatry. 2000 Sep 15;48(6):458-66
references.pmid: 11018219
references.citation: Psychopharmacol Bull. 1985;21(4):809-43
references.pmid: 4089107
references.citation: J Clin Psychiatry. 2010 Jul;71(7):864-72
references.pmid: 20667291
references.citation: CNS Spectr. 2005 Feb;10(2):141-8
references.pmid: 15685125
references.citation: J Affect Disord. 2012 Feb;136(3):1143-53
references.pmid: 22035648
references.citation: Can J Psychiatry. 2005 Oct;50(12):802-5
references.pmid: 16408529
references.citation: Psychopharmacology (Berl). 2007 Mar;191(1):39-54
references.pmid: 17093980
references.citation: J Clin Psychiatry. 2007 Oct;68(10):1565-73
references.pmid: 17960974
references.citation: J Clin Psychiatry. 2007 Jul;68(7):1088-93
references.pmid: 17685747
references.citation: CNS Neurosci Ther. 2012 Jan;18(1):28-33
references.pmid: 21114638
references.citation: J Child Adolesc Psychopharmacol. 2003 Winter;13(4):495-505
references.pmid: 14977462
references.citation: Biol Psychiatry. 2004 May 1;55(9):875-81
references.pmid: 15110730
references.citation: J Child Adolesc Psychopharmacol. 2004 Winter;14(4):593-600
references.pmid: 15662152
references.citation: J Affect Disord. 2011 Jul;132(1-2):270-4
references.pmid: 21334070
references.citation: J Clin Psychiatry. 2008;69 Suppl 4:26-36
references.pmid: 18533766
references.citation: J Pediatr. 2007 May;150(5):485-90
references.pmid: 17452221
references.citation: Arch Gen Psychiatry. 2008 Oct;65(10):1125-33
references.pmid: 18838629